Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

NCT00010309 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: gp100 antigen

Sponsor

Genzyme, a Sanofi Company